Exhibit 99.1

Visualant and Intellectual Ventures Join Forces to Accelerate Development of ChromaID Applications;

SDKs Begin Shipping the Week of November 18

Visualant Will Host a Conference Call Today at 2:30 p.m. PT to Discuss New Strategic Partnership

Seattle, WA – (November 14, 2013) – Visualant, Inc. (OTCQB: VSUL), a leading provider of disruptive light-based technologies, and Intellectual Ventures (IV), the global leader in the business of invention, have formed a strategic partnership to advance the commercialization of Visualant’s patented ChromaID™ technology through product applications and IP development.

ChromaID is a breakthrough light-based identification and measurement technology, with the potential to replace traditional spectral analysis and other costly methods of identification, authentication, and diagnosis.

IV will provide access to its global network of inventors and engineers to develop applications for ChromaID, including solutions for medical diagnostics, and food and drug safety. IV has also agreed to file a minimum of 10 patents covering these new ChromaID applications.

“Our new partnership with Intellectual Ventures is a tremendous validation of our technology,” said Visualant founder and CEO Ron Erickson. “Partnering with IV puts our technology in the hands of the world’s strongest IP development company, and its network of inventors and engineers.

“With the anticipated expansion of Visualant’s intellectual property, we expect to benefit immensely from IV’s global invention network, and highly successful business development and IP licensing teams. With IV’s assistance, we will put ChromaID technology into the hands of the world’s most innovative people at companies with tremendous capital and development resources, giving us great confidence that this disruptive technology will be soon be deployed in real-world applications.”

All of Visualant’s currently available ChromaID Scanner and Software Development Kit (SDK) inventory has been allocated and are scheduled to ship the week of November 18. Additional ChromaID Scanners and SDKs are being manufactured and scheduled for availability in early 2014.

“Visualant’s significant research and development investment has resulted in a truly revolutionary technology in ChromaID,” said Tim Londergan, head of commercial development for the Invention Development Fund at Intellectual Ventures. “We plan to expand the ChromaID patent portfolio as we develop innovative commercial applications.”

In addition to traditional IP licensing deals, companies work with IV's in-house inventors as well as its network of more than 4,000 inventors across ten countries to solve near-term technical issues and invent the technologies that will differentiate next-generation products from the competition. IV’s IP portfolio includes nearly 40,000 patent assets across more than 50 fields of technology.

Conference Call

Visualant’s president and CEO Ron Erickson will host a conference call today (November 14, 2013) at 2:30 p.m. Pacific time to discuss the strategic partnership. Tim Londergan, head of commercial development for the Invention Development Fund at Intellectual Ventures, will participate on the call. A question and answer session will follow the prepared remarks.

Date: Thursday, November 14, 2013

Time: 2:30 p.m. Pacific time (5:30 p.m. Eastern time)

Dial-in number: 1-877-941-2321

International number: 1-480-629-9666

Conference ID: 4650657

The presentation will be webcast live and available for replay via the Investors section of Visualant’s website at www.visualant.net.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.